Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer. Clin. Immunol. 140, 167–176 (2011). Article CAS PubMed Google Scholar Exley, M. A. et al. Adoptive transfer of invariant NKT cells as immunotherapy for advanced melanoma: a ...
6 Detection of CAR-NKT cells in treated patients pre- and post-infusion. Flow cytometry staining showing iNKT+Vβ11+ cells after gating on CD3+ cells and corresponding GD2-CAR expression in patients at indicated timepoints. T-cells served as a negative control for CAR staining. N.D.: not...
开始日期 Phase II Study of Ex-Vivo Expanded Allogeneic Universal Donor TGFβi NK Cell Infusions in Combination With Temozolomide, Irinotecan, Dinutuximab, and Sargramostim in Patients With Relapsed or Refractory Neuroblastoma The STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial...